Skip to content
2000
Volume 22, Issue 1
  • ISSN: 1566-5232
  • E-ISSN: 1875-5631

Abstract

Background: Radiation-induced lung injury (RILI) is lacking effective therapeutic strategies. In this study, we conducted -based CRISPR/Cas9 gene therapy for RILI. Objective: Mouse lungs were irradiated with a single-dose of 20-Gy gamma rays followed by intravenous administration of Ad-CRISPR- or Ad- CRISPR-Null. Methods: Haematoxylin and eosin staining, as well as Masson staining, were performed to observe lung morphology. Albumin and IgM concentrations in bronchoalveolar lavage fluid were measured by ELISA. Cytokine levels were measured using ELISA and/or real-time PCR with terminal deoxynucleotidyl transferase-mediated nick-end labelling. Results: Ad-CRISPR-T improved histopathological and biochemical markers of lung injury, reduced secretion and expression of inflammatory cytokines, and inhibited progression of fibrosis. Importantly, the SK1/S1P axis, which is known to play a key role S1P1 in -dependent S1PR pattern remodelling, is responsible for promoting fibrosis. Conclusion: Our results indicate novel insights for RILI therapy.

Loading

Article metrics loading...

/content/journals/cgt/10.2174/1566523220666201230100523
2022-02-01
2025-06-11
Loading full text...

Full text loading...

/content/journals/cgt/10.2174/1566523220666201230100523
Loading

  • Article Type:
    Research Article
Keyword(s): CRISPR/Cas9; fibrosis; gene therapy; inflammation; lung
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test